The results of this study further demonstrated a central role for the PI3K/AKT pathway in the regulation of Sox11 expression as a mechanism facilitating the maintenance of tumour cell survival and proliferation, providing a foundation to guide future OSCC treatment. This evidence concerns the gene AKT1 and neoplasm.